A randomised controlled trial of clinical and cost-effectiveness of the PASS Plus intervention for young children with autism spectrum disorder in New Delhi, India: study protocol for the COMPASS trial.
- DOI
- 10.1186/s13063-023-07621-5
- Published
- 2023 Oct 12
- Container
- Trials
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s13063-023-07621-5,
title = {A randomised controlled trial of clinical and cost-effectiveness of the PASS Plus intervention for young children with autism spectrum disorder in New Delhi, India: study protocol for the COMPASS trial.},
author = {Roy R and Leadbitter K and Shields G and Taylor C and Aldred C and Juneja M and Gulati S and Vajaratkar V and Davies L and Emsley R and Patel V and Divan G and Green J and COMPASS team},
year = {2023},
journal = {Trials},
doi = {10.1186/s13063-023-07621-5},
url = {https://doi.org/10.1186/s13063-023-07621-5}
}RIS
TY - JOUR TI - A randomised controlled trial of clinical and cost-effectiveness of the PASS Plus intervention for young children with autism spectrum disorder in New Delhi, India: study protocol for the COMPASS trial. AU - Roy R AU - Leadbitter K AU - Shields G AU - Taylor C AU - Aldred C AU - Juneja M AU - Gulati S AU - Vajaratkar V AU - Davies L AU - Emsley R AU - Patel V AU - Divan G AU - Green J AU - COMPASS team PY - 2023 JO - Trials DO - 10.1186/s13063-023-07621-5 UR - https://doi.org/10.1186/s13063-023-07621-5 ER -
APA
R, R., K, L., G, S., C, T., C, A., M, J., S, G., V, V., L, D., R, E., V, P., G, D., J, G., & team, C. (2023). A randomised controlled trial of clinical and cost-effectiveness of the PASS Plus intervention for young children with autism spectrum disorder in New Delhi, India: study protocol for the COMPASS trial.. Trials. https://doi.org/10.1186/s13063-023-07621-5
Source records
- pubmed · retrieved 2026-09-26T00:45:21.779Z